Human Genetics and Phenotyping Core

人类遗传学和表型核心

基本信息

  • 批准号:
    10628912
  • 负责人:
  • 金额:
    $ 30.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-15 至 2028-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY This core is central for all experiments in this program project and capitalizes on the Pakistan Genomic Resource (PGR) that has established the largest biobank of “Human Knockouts”. Specifically, PGR has leveraged high levels of consanguinity in Pakistan and has conducted whole-exome and whole-genome sequencing studies in 80,000 participants and has already identified complete KOs for >5000 genes and heterozygous KOs for >18,000 genes. PGR has also found rare homozygotes for many missense variants, many of which have now been characterized to be loss of function (LoF) or gain of function (GoF). Moreover, PGR has also recruited > 45,000 cases with myocardial infarction, > 20,000 cases with echo-confirmed heart failure, > 6,000 cases with imaging confirmed stroke – all of these participants have undergone genotyping for GWAS and whole-exome sequencing studies. Services that will be provided by the core will include: (i) for high priority genes across the four projects, deep phenotyping of KOs / mutant probands and their consanguineous family members. Such phenotyping studies will include: detailed clinical exams, electrocardiograms (ECGs) and echocardiograms, assessment of any rhythm disorders through Biotel patch heart monitors, exercise stress test, and detailed biochemical exams; (ii) analyses of large-scale genomic data in relation to cardiovascular traits and outcomes (i.e., myocardial infarction, stroke, heart failure, ECG traits and other risk factors) recorded in PGR, UKBiobank and other population-based resources in up to 1 million participants.
项目摘要 该核心是该计划项目中所有实验的核心,并利用了巴基斯坦基因组资源 (PGR)建立了世界上最大的“人类基因库”具体来说,PGR的杠杆率很高 在巴基斯坦进行了全外显子组和全基因组测序研究, 80,000名参与者,并且已经确定了>5000个基因的完全科斯和> 18,000个基因的杂合科斯 基因. PCR还发现了许多错义变体的罕见纯合子,其中许多现在已经被发现。 其特征在于功能丧失(LoF)或功能获得(GoF)。此外,PGR还招募了> 45 000人 心肌梗死例,超声心动图证实的心力衰竭> 20,000例,影像学检查> 6,000例 确诊的卒中-所有这些参与者都进行了GWAS基因分型和全外显子组测序 问题研究核心将提供的服务包括:(i)对于四个项目中的高优先级基因, 对科斯/突变先证者及其近亲家族成员进行深度表型分型。这种表型 研究将包括:详细的临床检查、心电图(ECG)和超声心动图、 通过Biotel贴片心脏监测仪、运动负荷试验和详细的生化检查发现任何心律紊乱; (ii)分析与心血管特征和结果相关的大规模基因组数据(即,心肌 梗死、中风、心力衰竭、ECG特征和其他风险因素)记录在PGR、UKBiobank和其他 以人口为基础的资源,多达100万参与者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Danish Saleheen其他文献

Danish Saleheen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Danish Saleheen', 18)}}的其他基金

Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
通过人类基因敲除的深入表型分析和机制研究发现 NASH 的新治疗靶点
  • 批准号:
    10698154
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
通过人类基因敲除的深入表型分析和机制研究发现 NASH 的新治疗靶点
  • 批准号:
    10504666
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
Leveraging consanguinity and homozygosity to identify novel recessive variants
利用血缘和纯合性来识别新的隐性变异
  • 批准号:
    10440463
  • 财政年份:
    2019
  • 资助金额:
    $ 30.15万
  • 项目类别:
Leveraging consanguinity and homozygosity to identify novel recessive variants
利用血缘和纯合性来识别新的隐性变异
  • 批准号:
    9803204
  • 财政年份:
    2019
  • 资助金额:
    $ 30.15万
  • 项目类别:
Leveraging consanguinity and homozygosity to identify novel recessive variants
利用血缘和纯合性来识别新的隐性变异
  • 批准号:
    10018068
  • 财政年份:
    2019
  • 资助金额:
    $ 30.15万
  • 项目类别:
Leveraging consanguinity and homozygosity to identify novel recessive variants
利用血缘和纯合性来识别新的隐性变异
  • 批准号:
    10200877
  • 财政年份:
    2019
  • 资助金额:
    $ 30.15万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 30.15万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 30.15万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 30.15万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 30.15万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 30.15万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 30.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了